MiddleBrook to sell assets to Victory Pharma
This article was originally published in Scrip
Executive Summary
MiddleBrook Pharmaceuticals has agreed to sell substantially all of its assets, and certain liabilities, to fellow US firm Victory Pharma for around $17 million.